Spatial Statistics Methods for the Analysis of Chemical Datasets in Virtual Screening Validation Experiments
暂无分享,去创建一个
[1] C. Matayatsuk,et al. 3D-QSAR studies on phthalimide derivatives as HIV-1 reverse transcriptase inhibitors , 2004 .
[2] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[3] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[4] Esa Alhoniemi,et al. Self-organizing map in Matlab: the SOM Toolbox , 1999 .
[5] Peter Meier,et al. Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection. , 2005, Current topics in medicinal chemistry.
[6] Yong-Jin Xu,et al. Using Molecular Equivalence Numbers to Visually Explore Structural Features that Distinguish Chemical Libraries. , 2002 .
[7] Robert D. Clark,et al. OptiSim: An Extended Dissimilarity Selection Method for Finding Diverse Representative Subsets , 1997, J. Chem. Inf. Comput. Sci..
[8] Anthony E. Klon,et al. Application of Machine Learning To Improve the Results of High-Throughput Docking Against the HIV-1 Protease , 2004, Journal of Chemical Information and Modeling.
[9] Christopher P Austin,et al. Characterization of chemical libraries for luciferase inhibitory activity. , 2008, Journal of medicinal chemistry.
[10] P. Willett,et al. Enhancing the effectiveness of similarity-based virtual screening using nearest-neighbor information. , 2005, Journal of medicinal chemistry.
[11] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.
[12] Jason A. Wiles,et al. Small molecule inhibitors of E. coli primase, a novel bacterial target. , 2007, Bioorganic & medicinal chemistry letters.
[13] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[14] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[15] D. Rognan,et al. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.
[16] Alexander Golbraikh,et al. Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening , 2008, J. Comput. Aided Mol. Des..
[17] Malcolm J. McGregor,et al. Clustering of Large Databases of Compounds: Using the MDL "Keys" as Structural Descriptors , 1997, J. Chem. Inf. Comput. Sci..
[18] A. Mironov,et al. Infrared spectra of pyrroles and dipyrrylmethanes , 1965 .
[19] A. Hopkins,et al. Navigating chemical space for biology and medicine , 2004, Nature.
[20] Jürgen Bajorath,et al. Bayesian Interpretation of a Distance Function for Navigating High-Dimensional Descriptor Spaces. , 2007 .
[21] Gisbert Schneider,et al. Processing and classification of chemical data inspired by insect olfaction , 2007, Proceedings of the National Academy of Sciences.
[22] E. Jaeger,et al. Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.
[23] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[24] J. Pin,et al. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.
[25] Andrew C. Good,et al. An Empirical Process for the Design of High-Throughput Screening Deck Filters. , 2006 .
[26] Knut Baumann,et al. Impact of Benchmark Data Set Topology on the Validation of Virtual Screening Methods: Exploration and Quantification by Spatial Statistics , 2008, J. Chem. Inf. Model..
[27] Wolf-Dietrich Ihlenfeldt,et al. Computation and management of chemical properties in CACTVS: An extensible networked approach toward modularity and compatibility , 1994, J. Chem. Inf. Comput. Sci..
[28] R. Flower. The development of COX2 inhibitors , 2003, Nature Reviews Drug Discovery.
[29] Jürgen Bajorath,et al. Molecular Similarity Analysis and Virtual Screening by Mapping of Consensus Positions in Binary-Transformed Chemical Descriptor Spaces with Variable Dimensionality , 2004, J. Chem. Inf. Model..
[30] Jürgen Bajorath,et al. New methodologies for ligand-based virtual screening. , 2005, Current pharmaceutical design.
[31] Thomas Lengauer,et al. Ensemble Methods for Classification in Cheminformatics , 2004, J. Chem. Inf. Model..
[32] V. A. Zagorevskii,et al. Synthesis and pharmacological activity of 4H-[1]-benzopyrano[3,4-d]imidazol-4-ones , 1983, Pharmaceutical Chemistry Journal.
[33] M. Kukhanova,et al. New triphosphate conjugates bearing reporter groups: labeling of DNA fragments for microarray analysis. , 2007, Bioconjugate chemistry.
[34] Robert Nadon,et al. Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.
[35] W. Patrick Walters,et al. A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.
[36] Ian A. Watson,et al. ErG: 2D Pharmacophore Descriptions for Scaffold Hopping. , 2006 .
[37] L. Dekker,et al. Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain. , 2004, Drug discovery today.
[38] Tudor I. Oprea,et al. Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? , 2008, J. Comput. Aided Mol. Des..
[39] Yvonne C. Martin,et al. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..
[40] Jürgen Bajorath,et al. Introduction of a Generally Applicable Method to Estimate Retrieval of Active Molecules for Similarity Searching using Fingerprints , 2007, ChemMedChem.
[41] Richard D. Taylor,et al. Virtual Screening Using Protein—Ligand Docking: Avoiding Artificial Enrichment. , 2004 .
[42] M. E. Johnson,et al. Some Guidelines for Constructing Exact D-Optimal Designs on Convex Design Spaces , 1983 .
[43] Ing-Marie Olsson,et al. D-optimal onion designs in statistical molecular design , 2004 .
[44] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology , 2003, Nucleic Acids Res..
[45] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[46] N. Stiefl,et al. Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique. , 2003, Journal of medicinal chemistry.
[47] Anthony C. Atkinson,et al. Optimum Experimental Designs , 1992 .
[48] P. Gund. Three-Dimensional Pharmacophoric Pattern Searching , 1977 .
[49] G. Schneider,et al. Virtual Screening for Bioactive Molecules , 2000 .
[50] Rodrigo Lopez,et al. Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..
[51] B. Shoichet,et al. High-throughput assays for promiscuous inhibitors , 2005, Nature chemical biology.
[52] P. Hawkins,et al. Comparison of shape-matching and docking as virtual screening tools. , 2007, Journal of medicinal chemistry.
[53] Bin Zhou,et al. Large-Scale Annotation of Small-Molecule Libraries Using Public Databases , 2007, J. Chem. Inf. Model..
[54] Ajay N. Jain,et al. Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.
[55] Andreas Bender,et al. A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication , 2005, J. Chem. Inf. Model..
[56] Walter Sneader,et al. Drug Discovery (The History) , 2005 .
[57] P. Jaccard. Distribution de la flore alpine dans le bassin des Dranses et dans quelques régions voisines , 1901 .
[58] Paul Ehrlich. Über den jetzigen Stand der Chemotherapie , 1960 .
[59] J. Mandel. Use of the Singular Value Decomposition in Regression Analysis , 1982 .
[60] Ajay N. Jain,et al. Parameter estimation for scoring protein-ligand interactions using negative training data. , 2006, Journal of medicinal chemistry.
[61] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[62] Zsolt Zsoldos,et al. LASSO—ligand activity by surface similarity order: a new tool for ligand based virtual screening , 2008, J. Comput. Aided Mol. Des..
[63] Andrew C. Good,et al. Measuring CAMD Technique Performance, 2. How "Druglike" Are Drugs? Implications of Random Test Set Selection Exemplified Using Druglikeness Classification Models , 2007, J. Chem. Inf. Model..
[64] J. Alvarez. High-throughput docking as a source of novel drug leads. , 2004, Current opinion in chemical biology.
[65] Andreas Bender,et al. Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data , 2007, J. Chem. Inf. Model..
[66] Robert D Clark,et al. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.
[67] Jürgen Bajorath,et al. Introduction of an Information-Theoretic Method to Predict Recovery Rates of Active Compounds for Bayesian in Silico Screening: Theory and Screening Trials , 2007, J. Chem. Inf. Model..
[68] Thomas Gärtner,et al. Support-Vector-Machine-Based Ranking Significantly Improves the Effectiveness of Similarity Searching Using 2D Fingerprints and Multiple Reference Compounds , 2008, J. Chem. Inf. Model..
[69] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[70] J. Bajorath. Selected Concepts and Investigations in Compound Classification, Molecular Descriptor Analysis, and Virtual Screening , 2001 .
[71] Ajay N. Jain,et al. Recommendations for evaluation of computational methods , 2008, J. Comput. Aided Mol. Des..
[72] Samuel Kaski,et al. Comparing Self-Organizing Maps , 1996, ICANN.
[73] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[74] J. Irwin,et al. ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. , 2005 .
[75] Ing-Marie Olsson,et al. Controlling coverage of D‐optimal onion designs and selections , 2004 .
[76] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[77] E. Fluder,et al. Protocols for Bridging the Peptide to Nonpeptide Gap in Topological Similarity Searches. , 2001 .
[78] Christopher P Austin,et al. A high-throughput screen for aggregation-based inhibition in a large compound library. , 2007, Journal of medicinal chemistry.
[79] Shigeo Yamamoto,et al. Structure-activity Relationships of Fungicidal N-Benzoylanthranilic Esters , 1980 .
[80] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[81] J. B. Paine,et al. Pyrrole Chemistry. An Improved Synthesis of Ethyl Pyrrole-2-carboxylate Esters from Diethyl Aminomalonate. , 1986 .
[82] T. Bailey. Spatial Analysis: A Guide for Ecologists , 2006 .
[83] John J. Irwin,et al. Community benchmarks for virtual screening , 2008, J. Comput. Aided Mol. Des..
[84] P. Hänninen,et al. Syntheses of Novel Dipyrrylmethene-BF2 Dyes and Their Performance as Labels in Two-Photon Excited Fluoroimmunoassay , 2004, Journal of Fluorescence.
[85] Wolfgang Guba,et al. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.
[86] Z. Trávníček,et al. Metal complexes as anticancer agents 2. Iron(III) and copper(II) bio-active complexes with N6-benzylaminopurine derivatives , 2001 .
[87] M Rarey,et al. Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.
[88] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[89] E. Zerhouni. The NIH Roadmap , 2003, Science.
[90] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[91] N. R. Williams,et al. 772. Pyrroles and related compounds. Part I. Syntheses of some unsymmetrical pyrrolylmethylpyrroles (pyrromethanes) , 1958 .
[92] Adam Yasgar,et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[93] Jun Xu. A new approach to finding natural chemical structure classes. , 2002, Journal of medicinal chemistry.
[94] Jérôme Hert,et al. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..
[95] Martin Stahl,et al. Scoring functions for protein-ligand interactions: a critical perspective. , 2004, Drug discovery today. Technologies.
[96] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[97] L. A. Stone,et al. Computer Aided Design of Experiments , 1969 .
[98] M. Petrova,et al. The Reaction of 2-Aminoethyl- and 3-Aminopropyl-substituted Heterocycles with 2-Formyl-1,3-cyclanediones and 4-Oxo-3,1-benzoxazines , 2002 .
[99] Esa Alhoniemi,et al. Clustering of the self-organizing map , 2000, IEEE Trans. Neural Networks Learn. Syst..
[100] P. Charifson,et al. Improved scoring of ligand-protein interactions using OWFEG free energy grids. , 2001, Journal of medicinal chemistry.
[101] C. Spearman. The proof and measurement of association between two things. , 2015, International journal of epidemiology.
[102] Ruili Huang,et al. Fluorescence spectroscopic profiling of compound libraries. , 2008, Journal of medicinal chemistry.
[103] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[104] Knut Baumann,et al. An Alignment-Independent Versatile Structure Descriptor for QSAR and QSPR Based on the Distribution of Molecular Features , 2002, J. Chem. Inf. Comput. Sci..
[105] B. Shoichet. Screening in a spirit haunted world. , 2006, Drug discovery today.
[106] Andrew C. Good,et al. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..
[107] Yvonne C. Martin,et al. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding , 1997, J. Chem. Inf. Comput. Sci..
[108] Gerhard Hessler,et al. Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.